Literature DB >> 2537156

Identification of alpha 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopathic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein.

T Vago1, M Bevilacqua, G Norbiato, G Baldi, E Chebat, P Bertora, G Baroldi, R Accinni.   

Abstract

Discontinuous density sucrose gradient centrifugation was used to isolate membrane vesicles from the left ventricle of three normal subjects (one prospective organ donor and two traffic victims whose hearts were obtained 1 hour after death) and nine patients undergoing cardiac transplantation as a consequence of idiopathic dilated cardiomyopathy. Sarcolemma-enriched subcellular fractions, detected in the interface between 8.55% and 25% sucrose, were identified by the increased activity of Na+,K+-ATPase and by enrichment in beta-adrenergic receptor density. The density of beta-adrenergic receptors was lower in vesicles from diseased hearts (610 +/- 71 fmol/mg protein) than in vesicles from normal hearts (1,410 +/- 226 fmol/mg protein; p less than 0.01). alpha 1-Adrenergic receptors were identified in these membrane vesicles by [3H]prazosin binding. Specific binding of [3H]prazosin was about 50% of the total binding at 1 nM, and alpha 1-adrenergic binding sites were saturable at approximately 3 nM. Scatchard analysis revealed 58 +/- 5 fmol/mg protein (KD = 0.90 +/- 0.08 nM) in pathological hearts and 30 +/- 5 fmol/mg protein (KD = 0.90 +/- 0.03 nM) in normal hearts (p less than 0.01). The displacement curve of (-)-norepinephrine in membrane vesicles from normal hearts delineated one subpopulation of alpha 1-adrenergic receptors; the addition of 0.1 mM GTP did not cause right shift. In membrane vesicles from diseased heart, the displacement curve of (-)-norepinephrine disclosed two subpopulations of alpha 1-adrenergic receptors. A right shift that occurred after addition of GTP showed that in this case alpha 1-adrenergic receptors were functionally coupled with GTP-binding protein.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537156     DOI: 10.1161/01.res.64.3.474

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Carvedilol tratment of chronic heart failure: a new era.

Authors:  M Bristow
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 2.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

3.  Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins.

Authors:  Ting Shi; Christine S Moravec; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2013-02-06       Impact factor: 2.092

4.  Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.

Authors:  T Vago; M Bevilacqua; F Conci; G Baldi; E Ongini; E Chebat; A Monopoli; G Norbiato
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

5.  Cardiac alpha 1-adrenoceptor densities in different mammalian species.

Authors:  M Steinfath; Y Y Chen; J Lavický; O Magnussen; M Nose; S Rosswag; W Schmitz; H Scholz
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

Review 6.  Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.

Authors:  Timothy D O'Connell; Brian C Jensen; Anthony J Baker; Paul C Simpson
Journal:  Pharmacol Rev       Date:  2013-12-24       Impact factor: 25.468

7.  Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.

Authors:  K Kiuchi; R P Shannon; K Komamura; D J Cohen; C Bianchi; C J Homcy; S F Vatner; D E Vatner
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma.

Authors:  M Bevilacqua; T Vago; G Norbiato
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

Review 9.  Changes in adrenergic receptors during the development of heart failure.

Authors:  N S Dhalla; I M Dixon; S Suzuki; M Kaneko; A Kobayashi; R E Beamish
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

10.  Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.

Authors:  M Steinfath; W Danielsen; H von der Leyen; U Mende; W Meyer; J Neumann; M Nose; T Reich; W Schmitz; H Scholz
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.